OVID
Ovid Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.66 / 10
Netural
Technical analysis yields a neutral rating (5.66/10). Long Lower Shadow and Long Upper Shadow give modest bullish/neutral bias (scores 6.9 and 6.6), but RSI is overbought (3.5), suggesting short‑term downside risk.
Analysis Checks(2/3)
Long Lower Shadow
Score6.92/10
Win Rate56.12%
Hist. Signals98
Avg Return3.41%
Score6.92/10
Win Rate56.12%
Hist. Signals98
Avg Return3.41%
RSI Overbought
Score3.47/10
Win Rate46.43%
Hist. Signals28
Avg Return1.87%
Score3.47/10
Win Rate46.43%
Hist. Signals28
Avg Return1.87%
Long Upper Shadow
Score6.58/10
Win Rate53.85%
Hist. Signals65
Avg Return2.45%
Score6.58/10
Win Rate53.85%
Hist. Signals65
Avg Return2.45%
Long Lower Shadow
Score6.92/10
Win Rate56.12%
Hist. Signals98
Avg Return3.41%
Score6.92/10
Win Rate56.12%
Hist. Signals98
Avg Return3.41%
Long Upper Shadow
Score6.58/10
Win Rate53.85%
Hist. Signals65
Avg Return2.45%
Score6.58/10
Win Rate53.85%
Hist. Signals65
Avg Return2.45%
RSI Overbought
Score3.47/10
Win Rate46.43%
Hist. Signals28
Avg Return1.87%
Score3.47/10
Win Rate46.43%
Hist. Signals28
Avg Return1.87%
Technical Analysis of OVID?
- OVID presents a Netural setup with a Technical Score of 5.66/10. Key technical indicators highlight an RSI of 68.02 and a MACD of 0.11, with the trend anchored by the 50-Day SMA at 1.74. Traders should monitor key support at 2.45 and resistance at 2.67.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
